{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T11:25:46Z","timestamp":1760441146543},"reference-count":38,"publisher":"Japanese Pharmacological Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2013]]},"DOI":"10.1254\/jphs.12248fp","type":"journal-article","created":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T23:14:07Z","timestamp":1372720447000},"page":"184-192","source":"Crossref","is-referenced-by-count":8,"title":["Effect of bis-1,4-Dihydropyridine in the Kidney of Diabetic Rats"],"prefix":"10.1254","volume":"122","author":[{"given":"Raquel","family":"G\u00f3mez-Pliego","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"G\u00f3mez-Zamudio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjam\u00edn","family":"Velasco-Bejarano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximiliano","family":"Ibarra-Barajas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Villalobos-Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Staessen JA, Birkenh\u00e4ger WH, Fagard RH. Dihydropyridine calcium-channel blockers for the treatment of hypertensive diabetic patient. Eur Heart J. 2000;21:2\u20137.","DOI":"10.1053\/euhj.1999.1833"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Amenta F, Peleg E, Tomassoni D, Sabbatini M, Rosenthal T. Effect of treatment with lercanidipine on heart of Cohen-Rosenthal diabetic hypertensive rats. Hypertension. 2003;41:1330\u20131335.","DOI":"10.1161\/01.HYP.0000070116.11304.23"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Turner R. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J. 1998;317:703\u2013713.","DOI":"10.1136\/bmj.317.7160.703"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Gallego B, Ar\u00e9valo MA, Flores O, L\u00f3pez-Novoa JM, P\u00e9rez-Barriocanal F. Renal fibrosis in diabetic and aortic-constricted hypertensive rats. Am J Physiol. 2001;280:R1823\u2013R1829.","DOI":"10.1152\/ajpregu.2001.280.6.R1823"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Nosadini R, Tonolo G. Cardiovascular and renal protection in type 2 diabetes mellitus: The role of calcium channel blockers. J Am Soc Nephrol. 2002;13:S216\u2013S223.","DOI":"10.1097\/01.ASN.0000034687.62568.9B"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Sabbatini M, Leonardi A, Testa R, Vitaioli L, Amenta F. Effect of calcium antagonists on glomerular arterioles in spontaneously hypertensive rats. Hypertension. 2000;35:775\u2013779.","DOI":"10.1161\/01.HYP.35.3.775"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Tolins JP, Raij L. Comparison of converting enzyme inhibitor and calcium channel blockers in hypertensive glomerular injury. Hypertension. 1990;16:452\u2013461.","DOI":"10.1161\/01.HYP.16.4.452"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Herlitz H, Harris K, Risler T, Boner G, Bernheim J, Chanard J, et al. The effects of an ACE inhibitor and a calcium antagonist on the progression of renal disease: the Nephros Study. Nephrol Dial Transplant. 2001;16:2158\u20132165.","DOI":"10.1093\/ndt\/16.11.2158"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Kloke JH, Branten JA, Huysmans FT, Wetzels JF. Anthipertensive treatment of patients with proteinuric renal diseases: risks or benefits of calcium channel blockers? Kidney Int. 1998;53:1559\u20131573.","DOI":"10.1046\/j.1523-1755.1998.00912.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Hayashi K, Wakino S, Sugano N, Ozawa Y, Homma K, Saruta T. Ca<sup>2+<\/sup> channel subtypes and pharmacology in the kidney. Circ Res. 2007;100:342\u2013353.","DOI":"10.1161\/01.RES.0000256155.31133.49"},{"key":"11","unstructured":"11 Sabbatini M, Vitaioli L, Baldoni E, Amenta F. Nephroprotective effect of treatment with calcium channel blockers in spontaneously hypertensive rats. J Pharmacol Exp Ther. 2000;294:948\u2013954."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Carmines PK, Ohishi K, Ikenaga H. Functional impairment of renal afferent arteriolar voltage-gated calcium channels in rats with diabetes mellitus. J Clin Invest. 1996;98:2564\u20132571.","DOI":"10.1172\/JCI119075"},{"key":"13","unstructured":"13 Swarnalatha G, Prasanthi G, Sirisha N, Madhusudhana Chetty C. 1,4-Dihydropyridines: a multifunctional molecule- a review. Int J Chem Tech Res. 2011;3:75\u201389."},{"key":"14","unstructured":"14 G\u00f3mez-Pliego R, Osnaya R, Zamora I, Velasco-Bejarano B, Arroyo G, Ram\u00edrez San Juan E, et al. The Hantzsch ester production in a water-based biphasic medium, using infrared irradiation as the activating source. J Mex Chem Soc. 2007;51:181\u2013184."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Kano S, Ichihara K, Komatsu K, Satoh K. Comparative effects of azelnidipine and amlodipine on myocardial function and mortality after ischemia\/reperfusion in dogs. J Pharmacol Sci. 2011;116:181\u2013187.","DOI":"10.1254\/jphs.10260FP"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Bandyopadhyay D, Maldonado S, Banik BK. A microwave-assisted bismuth nitrate-catalyzed unique route toward 1,4-dihydropyridines. Molecules. 2012;17:2643\u20132662.","DOI":"10.3390\/molecules17032643"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Zhu S, Tu S, Gao Y, Miao C, Li T, Zhang X, et al. Synthesis of bis-1,4-dihydropyridine derivatives. Synth Comm. 2005;35:1011\u20131015.","DOI":"10.1081\/SCC-200054183"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Shirakura S, Sano J, Karasawa A, Kubo K. Protective effect of benidipine against the development of glomerular sclerosis in experimental nephrotic syndrome. Jpn J Pharmacol. 1992;59:461\u2013467.","DOI":"10.1254\/jjp.59.461"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 G\u00f3mez-Pliego R, Ram\u00edrez-San Juan E, Miranda R, Villalobos-Molina R, Delgado F, Osnaya, R, et al. Vasodilator effects of <i>bis<\/i>-dihydropyridines structurally related to nifedipine. Med Chem. 2006;2:527\u2013534.","DOI":"10.2174\/157340606778250243"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Castro-Moreno P, Pardo JP, Hern\u00e1ndez-Mu\u00f1oz R, L\u00f3pez-Guerrero JJ, Del Valle-Mondrag\u00f3n L, Pastel\u00edn-Hern\u00e1ndez G, et al. Captopril avoids hypertension, the increase in plasma angiotensin II but increases angiotensin-(1-7) and angiotensin II-induced perfusion pressure in isolated kidney in SHR. Auton Autacoid Pharmacol. 2012;32:61\u201369.","DOI":"10.1111\/aap.12001"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin-Phenol reagent. J Biol Chem. 1951;193:265\u2013275.","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 American Diabetes Association. Clinical practice recommendations. Treatment of hypertension in adults with diabetes mellitus. Diabetes Care. 2002;25:S71\u2013S73.","DOI":"10.2337\/diacare.25.2007.S71"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Triggle DJ. 1,4-Dihydropyridines as calcium channel ligands and privileged structures. Cell Mol Neurobiol. 2003;23:293\u2013303.","DOI":"10.1023\/A:1023632419813"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Sydow K, Mondon CE, Cooke JP. Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA. Vasc Med. 2005;10:S34\u2013S43.","DOI":"10.1191\/1358863x05vm604oa"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Lampinen KH, R\u00f6nnback M, Groop P-H, Kaaja RJ. A relationship between insulin sensitivity and vasodilation in women with a history of preeclamptic pregnancy. Hypertension. 2008;52:394\u2013401.","DOI":"10.1161\/HYPERTENSIONAHA.108.113423"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Briede J, Stivrina M, Stoldere D, Bisenieks E, Uldri\u0137is J, Poik\u0101ns J, et al. Effect of new and known 1,4-dihydropyridine derivatives on blood glucose levels in normal and streptozotocin-induced diabetic rats. Cell Biochem Funct. 2004;22:219\u2013224.","DOI":"10.1002\/cbf.1091"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Luan J, Li W, Han J, Zhang W, Gong H, Ma R. Renal protection of in vivo administration of tempol in streptozotocin-induced diabetic rats. J Pharmacol Sci. 2012;119:167\u2013176.","DOI":"10.1254\/jphs.12002FP"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Jyothirmayi GN, Reddi AS. Effect of diltiazen on glomerular heparan sulfate and albuminuria in diabetic rats. Hypertension. 1993;21:795\u2013802.","DOI":"10.1161\/01.HYP.21.6.795"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Kamata K, Hosokawa M, Matsumoto T, Kobayashi T. Altered arachidonic acid-mediated responses in the perfused kidney of the streptozotocin-induced diabetic rats? J Smooth Muscle Res. 2006;42:171\u2013187.","DOI":"10.1540\/jsmr.42.171"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Cadaval RAM, Kohlman O, Michelacci Y. Urinary excretion of glycosaminoglycans and albumin in experimental diabetes mellitus. Glycobiology. 2000;10:185\u2013192.","DOI":"10.1093\/glycob\/10.2.185"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Viberti G, Wheeldon NM. Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: A blood pressure-independent effect. Circulation. 2002;106:672\u2013678.","DOI":"10.1161\/01.CIR.0000024416.33113.0A"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Galan BE, Perkovic V, Ninomiya T. Lowering blood pressure reduces renal events in type 2 diabetes. J Am Soc Nephrol. 2009;20:883\u2013892.","DOI":"10.1681\/ASN.2008070667"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Tonomura Y, Uehara T, Yamamoto E, Torii M, Matsubara M. Decrease in urinary creatinine in acute kidney injury influences diagnostic value of urinary biomarker-to-creatinine ratio in rats. Toxicology. 2011;290:241\u2013248.","DOI":"10.1016\/j.tox.2011.10.001"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Carvounis CP, Nisar S, Guro-Razuman S. Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney Int. 2002;62:2223\u20132229.","DOI":"10.1046\/j.1523-1755.2002.00683.x"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Dworkin LD. Impact of calcium entry blockers on glomerular injury in experimental hypertension. Cardiovasc Drugs Ther. 1990;4:1325\u20131330.","DOI":"10.1007\/BF02018259"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Ward DT, Yau SK, Mee AP, Mawer EB, Miller CA, Garland HO, et al. Functional, molecular, and biochemical characterization of streptozotocin-induced diabetes. J Am Soc Nephrol. 2001;12:779\u2013790.","DOI":"10.1681\/ASN.V124779"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Blue DR, Vimont RL, Clarke DE. Evidence for a noradrenergic innervation to <i>\u03b1<\/i>-<sub>1A<\/sub> adrenoceptors in rat kidney. Br J Pharmacol. 1992;107:414\u2013417.","DOI":"10.1111\/j.1476-5381.1992.tb12760.x"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Yao K, Nagashima K, Miki H. Pharmacological, pharmacokinetic, and clinical properties of benidipine hydrochloride, a novel, long-acting calcium channel blocker. J Pharmacol Sci. 2006;100:243\u2013261.","DOI":"10.1254\/jphs.DTJ05001X"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jphs\/122\/3\/122_12248FP\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T00:01:23Z","timestamp":1645920083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jphs\/122\/3\/122_12248FP\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.12248fp","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"value":"1347-8613","type":"print"},{"value":"1347-8648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}